Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2025-12-26 @ 2:57 AM
Study NCT ID:
NCT00940602
Status:
COMPLETED
Last Update Posted:
2020-11-23
First Post:
2009-07-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-03-22
Start Date Type:
ACTUAL
Primary Completion Date:
2018-02-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-02-27
Completion Date Type:
ACTUAL
First Submit Date:
2009-07-15
First Submit QC Date:
None
Study First Post Date:
2009-07-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-02-25
Results First Submit QC Date:
None
Results First Post Date:
2020-11-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-30
Last Update Post Date:
2020-11-23
Last Update Post Date Type:
ACTUAL